AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Illumina to Webcast Upcoming Investor Conference Presentation

December 23, 2019 GMT

SAN DIEGO--(BUSINESS WIRE)--Dec 23, 2019--

Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference and invite investors to participate via webcast.

J.P. Morgan Healthcare Conference in San Francisco, CA on Monday, January 13, 2020
Presentation at 8:30am Pacific Time followed by a Q&A Session at 9am Pacific Time

The live webcasts can be accessed in the Investor Relations section of Illumina’s website under the “company” tab at www.illumina.com. Replays will be posted on Illumina’s website after the event and will be available for at least 30 days following.

About Illumina

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and follow @illumina.

View source version on businesswire.com:https://www.businesswire.com/news/home/20191223005592/en/

CONTACT: Investors:

Jacquie Ross, CFA

858-882-2172

ir@illumina.comMedia:

Eric Endicott

858-882-6822

pr@illumina.com

KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: HEALTH COMMUNICATIONS GENETICS OTHER SCIENCE GENERAL HEALTH SCIENCE PUBLIC RELATIONS/INVESTOR RELATIONS

SOURCE: Illumina, Inc.

Copyright Business Wire 2019.

PUB: 12/23/2019 05:42 PM/DISC: 12/23/2019 05:42 PM

http://www.businesswire.com/news/home/20191223005592/en